DK145121B - ANALOGY PROCEDURE FOR PREPARATION OF 5 (6) - ((CYCLOPROPYLETHYL) -SULPHINYL) -BENZIMIDAZOL-2-METHYL CARBAMATE - Google Patents

ANALOGY PROCEDURE FOR PREPARATION OF 5 (6) - ((CYCLOPROPYLETHYL) -SULPHINYL) -BENZIMIDAZOL-2-METHYL CARBAMATE Download PDF

Info

Publication number
DK145121B
DK145121B DK442378AA DK442378A DK145121B DK 145121 B DK145121 B DK 145121B DK 442378A A DK442378A A DK 442378AA DK 442378 A DK442378 A DK 442378A DK 145121 B DK145121 B DK 145121B
Authority
DK
Denmark
Prior art keywords
preparation
cyclopropylethyl
sulphinyl
benzimidazol
methyl carbamate
Prior art date
Application number
DK442378AA
Other languages
Danish (da)
Other versions
DK145121C (en
DK442378A (en
Inventor
P Piccardi
G Confalonieri
P G Ramella
L D Col
Original Assignee
Montedison Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montedison Spa filed Critical Montedison Spa
Publication of DK442378A publication Critical patent/DK442378A/en
Publication of DK145121B publication Critical patent/DK145121B/en
Application granted granted Critical
Publication of DK145121C publication Critical patent/DK145121C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • C07D235/32Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/23Preparation of halogenated hydrocarbons by dehalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/272Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by addition reactions
    • C07C17/275Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by addition reactions of hydrocarbons and halogenated hydrocarbons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

i 145121in 145121

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af 5(6)-jjcyclopropylethylsulfinyl]-benzimidazol-2-methylcarbamat, der er et hidtil ukendt ben-zimidazolcarbamat, der kan anvendes i passende formuleringer til bekæmpelse af gastroenteritiske, lunge™, og hepa-tiske parasitter af den helmintiske type hos husdyr (kvæg, får, svin etc.). Fremgangsmåden er ejendommelig ved det i det i kravets kendetegnende del omhandlede.The present invention relates to an analogous process for the preparation of 5 (6) -cyclopropylethylsulfinyl] benzimidazole-2-methylcarbamate, a novel benzimidazole carbamate which can be used in suitable formulations for the control of gastroenteritic lung ™ and hepatic helminthic parasites of domestic animals (cattle, sheep, pigs, etc.). The process is peculiar to that described in the characterizing part of the claim.

5(6)-substituerede benzimidazoler er velkendte i litteraturen, og deres anti-helmintiske virkning er ligeledes velkendt (sammenlign f.eks. tysk patentansøgning nr. 2 029 637 og 2 164 690, fransk patentskrift nr. 1 556 824 og 2 052 988, britisk patentskrift nr. 1 455 728 jvf. s.5., USA patentskrift nr. 3 010 968 samt 3 915 986).5 (6) -substituted benzimidazoles are well known in the literature and their anti-helminthic action is also well known (compare, for example, German Patent Application Nos. 2 029 637 and 2,164,690, French Patent Nos. 1,556,824 and 2,052,988 , U.S. Patent No. 1,455,728, cf. p. 5, U.S. Patent No. 3,010,968 and 3,915,986).

Nogle af disse produkter er kommercielt tilgængelige såsom f.eks. Albendazol, Oxybendazol samt Perbendazol fremstillet af Smith-Kline and French Laboratories, Phenbendazol fremstillet af Hoechst Company, Oxphendazol, fremstillet af Syntex Co., Cambendazol samt Thiabendazol fremstillet af Merck Company og endelig Mebendazol fremstillet af Janssen Co.Some of these products are commercially available such as e.g. Albendazole, Oxybendazole and Perbendazole manufactured by Smith-Kline and French Laboratories, Phenbendazole manufactured by Hoechst Company, Oxphendazole, manufactured by Syntex Co., Cambendazole and Thiabendazole manufactured by Merck Company and finally Mebendazole manufactured by Janssen Co.

Alle disse forbindelser udviser god virkning overfor indvoldsorme; de er imidlertd kun lidt eller overhovedet ikke virksomme over for nematoder i lungen eller hepatiske tre-matoder.All of these compounds exhibit good activity against intestinal worms; however, they are only slightly or not at all effective against lung nematodes or hepatic triathematics.

Det har nu vist sig, at det hidtil udkendte benzimidazolcar-bamat, 5(6)-£(cyclopropylethyl)sulfinyl] -benzimidazol-2-methylcarbamat (CPSBC), med den almene formel: 0- m-C00CE3It has now been found that the heretofore known benzimidazole carbamate, 5 (6) - [(cyclopropylethyl) sulfinyl] benzimidazole-2-methylcarbamate (CPSBC), of the general formula: 0-m-C00CE3

HH

2 145121 udviser en større anti-helmintisk virkning over for specifikke kvæg-parasitter, end de benzimidazolcarbamater, som allerede er blevet indført i veterinær-praksis, og udviser et betydeligt bredere aktivitetsområde, idet den også er virksom over for nematoder i lungen og hepatiske trema-toder, som det ellers er vanskeligt at bekæmpe med konventionelle anti-helmintiske midler. Opfindelsen angår derfor en analogifremgangsmåde til fremstilling af den nævnte forbindelse, hvilken fremgangsmåde er ejendommelig ved det i kravets kendetegnende del anførte.2 145121 exhibits a greater anti-helminthic effect on specific bovine parasites than the benzimidazole carbamates already introduced in veterinary practice, and exhibits a significantly broader range of activity, also being effective against lung nematodes and hepatic trema. - spells that are otherwise difficult to combat with conventional anti-helminth agents. The invention therefore relates to an analogous method for the preparation of said compound, which is characterized by the characterizing part of the claim.

Forbindelsen fremstillet ifølge den foreliggende opfindelse udviser en usædvanlig effektivitet over for slægterne Ostertagia, Oesophagostomum, Trichostrongylus og andre indvoldsorme, og har endvidere vist sig aktiv over for Dictyo-cauli, Metastrongyli, protostrongyli, lungens nematoder, som er ansvarlig for infektioner, der kun vanskeligt kan holdes under kontrol, hos får, kvæg og heste; og de er yderligere også virkningsfulde overfor Fasciolae, såsom Fasciola hepatica.The compound of the present invention exhibits exceptional efficacy against the genera Ostertagia, Oesophagostomum, Trichostrongylus and other intestinal worms, and has also been shown to be active against Dictyo cauli, Metastrongyli, protostrongyli, the nematodes of the lung which are only responsible for infections, can be kept under control, in sheep, cattle and horses; and they are also effective against Fasciolae, such as Fasciola hepatica.

Fremstilling af udgangsforbindelserne til anvendelse ved fremgangsmåden ifølge opfindelsen frembyder ikke nogen særlige vanskeligheder. Forbindelsen kan fremstilles ud fra 2-nitro-4-thiocyano-anilin gennem følgende syntesetrin; hvor sidste trin illustrerer den omhandlede fremgangsmåde.Preparation of the starting compounds for use in the process of the invention presents no particular difficulties. The compound can be prepared from 2-nitro-4-thiocyano-aniline through the following synthesis steps; wherein the last step illustrates the present process.

3 145121 NHo NHp NHp A-. jLra nr*»3 145121 NHo NHp NHp A-. jLra nr * »

KJ e, Ljr -> KJKJ e, Ljr -> KJ

SCN SNa \ /x ηη2 m2 |^|-N02 NagSgO^ ^l-®2 M2 s_ch n i-NH-COOCH3 NH-COOCH3 KJ —^ ^SCN SNa \ / x ηη2 m2 | ^ | -N02 NagSgO ^^ l-®2 M2 s_ch n i-NH-COOCH3 NH-COOCH3 KJ - ^^

b CO-O-OHb CO-O-OH

^ ά (>A]Q[^)>-nh-cooch3 ^°^^-1Q]^nh_C00<ckbc)^ ά (> A] Q [^)> - nh-cooch3 ^ ° ^^ - 1Q] ^ nh_C00 <ckbc)

£ I£ I

HH

Cyclopropylethylchloridet kan fremstilles ud fra CCl^ og ethylen i overensstemmelse med efterfølgende reaktionsskema ch2 = ch2 cci4 + ch2 = ch2-> cci3-ch2-ch2-ci ->The cyclopropylethyl chloride can be prepared from CCl ^ and ethylene according to subsequent reaction scheme ch2 = ch2 cci4 + ch2 = ch2-> cci3-ch2-ch2-ci ->

Zn, HC1 i gasform -> ci-ch2 -ch2 - cci2 - ch2- ch2 - ci -*· tA^cl CPSBC har vist sig at være nyttig såvel til rensning af befængte dyr, som til beskyttelse mod infestation; det kan indgives ved hjælp af en hvilken som helst inden for veterinærvidenskaben kendt metode, f.eks. peroralt i form af kugler.Zn, HCl in gaseous form -> ci-ch2 -ch2 - cci2 - ch2- ch2 - ci - * · tA ^ cl CPSBC has been found to be useful both for the purification of infested animals and for protection against infestation; it can be administered by any method known in veterinary science, e.g. orally in the form of balls.

4 145121 tabletter, kapsler eller suspensioner, eller det kan direkte tilsættes foderet.4 145121 tablets, capsules or suspensions or it can be added directly to the feed.

Det er foreneligt med mange af de sædvanlige fortyndingsmidler eller strækkemidler, såsom f.eks. majsstivelse, lactose, saccharose, calciumphosphat, gelatine, stearinsyre, agar, pectin etc.It is compatible with many of the usual diluents or extenders, such as e.g. corn starch, lactose, sucrose, calcium phosphate, gelatin, stearic acid, agar, pectin etc.

Som flydende bærestoffer kan anvendes jordnøddeolie, olivenolie etc.As liquid carriers can be used peanut oil, olive oil etc.

Virkningsgraden af forbindelsen fremstillet ifølge den foreliggende opfindelse i sammenligning med hidtil kendte forbindelser er blevet fastlagt ved eksperimenter på får, der forinden var blevet grundigt befriet for infektion ved indgift af passende doser af konventionelle anti-helmin-tiske produkter, og som derpå blev infesteret under kontrol med parasitter tilhørende den art, der skulle undersøges.The efficacy of the compound prepared according to the present invention in comparison with previously known compounds has been determined by experiments on sheep which had previously been thoroughly liberated from infection by administration of appropriate doses of conventional anti-helminthic products and subsequently infested under control of parasites belonging to the species to be investigated.

De infesterede dyr blev derpå opdelt i to grupper, hvoraf den ene blev behandlet med en enkelt dosis af det produkt, der skulle undersøges, i form af en vandig suspension indgivet peroralt, mens den anden gruppe blev brugt som kontrolgruppe. 48 timer efter indgiften af det anti-helmin-tiske produkt blev dyrene slagtet, og de parasitter, der var til stede i dem, blev optalt i overensstemmelse med den inden for helmintologien sædvanlige fremgangsmåde.The infected animals were then divided into two groups, one of which was treated with a single dose of the product to be tested, in the form of an aqueous suspension administered orally, while the other group was used as a control group. Forty-eight hours after the administration of the anti-helminthic product, the animals were slaughtered and the parasites present in them were counted according to the usual method of helminthology.

Resultaterne blev udtrykt som procentvis des-infestation under anvendelse af følgende skala:The results were expressed as percent disinfection using the following scale:

Skalatrin % des-infestation 0 0- 10, eller betydningsløs 1 11- 25 2 26- 60 3 61- 90 4 91-100 5 145121Scale step% disinfection 0 0-10, or meaningless 1 11-25 2 26-60 3 61-90 4 91-100 5 145121

Tabel ITable I

Effektiviteten af CPSBS på får sammenlignet med analoge anti-helmintiske benzimidazoler.The effectiveness of CPSBS on sheep compared to analogue anti-helminthic benzimidazoles.

Arten af R Nematoder Cestoidei Trematoder i leddet éastroen- i lunger Moniezia Fasciola - τν,οΐβ teriske Djrctyo- hepaticaNature of R Nematodes Cestoidei Trematodes in the joint estrogen- in the lungs Moniezia Fasciola - τν, οΐβ terric Djrctyo hepatica

Ostertagia caulus T(6)T ^WH-CO^Wkg OesofagostomumOstertagia caulus T (6) T ^ WH-CO ^ Wkg Oesophagostomum

Tricbstrongylus ^ 5 4 4 4 4 2.5 4 4®Tricbstrongylus ^ 5 4 4 4 4 2.5 4 4®

VvA 5 4 3-4. 3 2 2.5 1 1 vV°v 5 ®® 0 O 0 ^y~S- 5 4 4 2-3 φφ® 2.5 2 2 ØSO- 5 4 4 4 1 2.5 4 4 <Q-CO- 5 2 3-4 2.5 - 0 - w 5 ®<g)®(g)® 0 Ø@(x)®@<x) p/nA 5 4 4 0 2 -r-CHg-SO- ^ 5 3 - o (1) Fremstillet ifølge britisk patentskrift nr. 1 455 728 φ ved 1 mg/kg eksisterer stadig total effektivitet.VvA 5 4 3-4. 3 2 2.5 1 1 vV ° v 5 ®® 0 O 0 ^ y ~ S- 5 4 4 2-3 φφ® 2.5 2 2 ØSO- 5 4 4 4 1 2.5 4 4 <Q-CO- 5 2 3-4 2.5 - 0 - w 5 ® <g) ® (g) ® 0 Ø @ (x) ® @ <x) p / nA 5 4 4 0 2 -r-CHg-SO- ^ 5 3 - o (1) Prepared According to British Patent Specification No. 1,455,728 φ at 1 mg / kg, total efficiency still exists.

φφ doser på 12,5 mg/kg er nødvendige for at opnå virkning 5 doser på 10 mg/kg kræves.φφ doses of 12.5 mg / kg are required to achieve efficacy 5 doses of 10 mg / kg are required.

φφφφ doser på mere end 25 mg/kg kræves.φφφφ doses greater than 25 mg / kg are required.

φφφφφ doser på 20 mg/kg kræves.φφφφφ doses of 20 mg / kg are required.

φφφφφφ doser på 60 mg/kg kræves.φφφφφφ doses of 60 mg / kg are required.

145121 6145121 6

Disse resultater viser den meget høje grad af effektivitet knyttet til CPSBC over for alle de undersøgte ormearter, i særdeleshed med hensyn til lunge-nematoder, samt trematoder, en virkningsgrad, som kun delvis forefindes tilsvarende ved oxiphendazol.These results show the very high degree of efficacy associated with CPSBC in all of the worm species studied, in particular with respect to lung nematodes, as well as trematodes, an efficiency which is only partially similar to oxiphendazole.

De angivne data viser yderligere at CPSBC indgivet i en enkelt dosis på 5 mg/kg muliggør total og samtidig des-in-festation hos får af nematoder, cestoider og trematoder, hvilket hidtil har været umuligt at opnå med noget kendt produkt anvendt alene.The data presented further shows that CPSBC administered at a single dose of 5 mg / kg allows total and simultaneous disinfection in sheep of nematodes, cestoids and trematodes, which has heretofore been impossible to achieve with any known product used alone.

Til bedre belysning af den foreliggende opfindelse er i det følgende anført nogle eksempler på syntetiseringen af 5(6)-[(cyclopropylethyl)sulfinyQ-benzimidazol-2-methylcarbamat, idet eksempel I-V illustrerer udgangsmaterialernes fremstilling og eksempel Vi fremgangsmåden ifølge opfindelsen.For better illustration of the present invention, some examples of the synthesis of 5 (6) - [(cyclopropylethyl) sulfinyl] benzimidazole-2-methylcarbamate are given below, Examples I-V illustrating the preparation of the starting materials and Example V of the process of the invention.

EKSEMPEL IEXAMPLE I

ccicci

Fremstilling af C3/*V 2-n//xC1 I en emaljeret 5 liter autoklav, der er forsynet med passende omrøringssystem og varmeregulering, blev anbragt 2,1 kg (11,5 mol) CC13-CH2-CH2-C1, i 1 liter CftjCN, 20 g FeCl2, 4H20, 22 g (C2H3)2~NH,HC1 samt 21 g benzoin. Luften blev derpå fjernet, og autoklaven blev sat under nogle få atmosfæres ethylentryk. Derpå blev temperaturen forøget til 120 °C, og der blev tilsat yderligere ethylen til opnåelse af et tryk på 35 atm. De anførte reaktionsbetingelser blev vedligeholdt i 5,5 time ved tilsætning af ethylen i takt med forbruget. Efter frafiltrering af de i suspension værende faste partikler, blev blandingen fraktioneret ved destillation, hvilket førte til 1300 g af en fraktion med kogepunkt 80-82 °C ved 2 mmHg,Preparation of C3 / * V 2-n // xC1 In an enamelled 5 liter autoclave equipped with appropriate stirring system and heat control, 2.1 kg (11.5 moles) of CC13-CH2-CH2-C1 were placed in 1 liter of Cft 2 CN, 20 g of FeCl 2, 4 H 2 O, 22 g (C 2 H 3) 2 NH, HCl and 21 g of benzoin. The air was then removed and the autoclave was put under a few atmospheres of ethylene pressure. Then the temperature was increased to 120 ° C and additional ethylene was added to give a pressure of 35 atm. The indicated reaction conditions were maintained for 5.5 hours by addition of ethylene as the consumption progressed. After filtering off the solid particles in suspension, the mixture was fractionated by distillation to give 1300 g of a boiling point 80-82 ° C fraction at 2 mmHg.

CCICCI

som bestod af 97%which consisted of 97%

Under de ovenfor anførte reaktionsbetingelser udgjorde omdannelsen af CC13CH2CH2C1 65%, medens selektiviteten med hensyn 7 145121 til det ønskede produkt var 80%, hvilket svarer til et totaludbytte på 52%.Under the above reaction conditions, the conversion of CC13CH2CH2C1 was 65%, while the selectivity with respect to the desired product was 80%, which corresponds to a total yield of 52%.

EKSEMPEL IIEXAMPLE II

Fremstilling af I en kolbe udrustet med tilbagesvaler, indboblingsrør, omrører pril og et termometer blev anbragt 210 g 1^N^S'Cl (1 mol), 1000 cm·^ ethanol og 325 g (5 mol) zinkpulver. Denne reaktionsblanding blev derpå opvarmet under tilbagesvaling (det ydre varmebadstemperatur var 97 0 - 98 °C), og derpå påbegyndtes gennembobling af gasformig HC1 igennem reaktions-beholderen under vedligeholdelse af en ringe, ensartet gennem-boblingsmængde; reaktionen blev fulgt ved hjælp af chromatografisk kontrol, og den blev afbrudt, uår syntes at være totalt omdannet. Reaktionsblandingen blev derpå fortyndet med 300 cm^ 5%’ig vandig HC1 for at gøre den mere tyndtflydende, og den blev derpå extraherét med diethylether, hvorpå den vandige fase blev fjernet. Den organiske fase blev efter tørring inddampet, og inddampningsresten blev fraktioneret ved atmosfæretryk, idet man opsamlede en fraktion med kp. 10S-111°C. Således opnåede man 86 g , som ved chroma- tografisk analyse viste sig at være 98% rent, dg^te svarer til et molært udbytte på 80% i forhold til Cl''"'Preparation of In a flask equipped with a reflux condenser, plug-in tube, stir barrel and a thermometer was placed 210 g of 1 N N 5 SCl (1 mole), 1000 cm 2 of ethanol and 325 g (5 mole) of zinc powder. This reaction mixture was then heated at reflux (the external hot bath temperature was 97 0 - 98 ° C) and then bubbling of gaseous HCl was started through the reaction vessel while maintaining a low uniform flow rate; the reaction was followed by chromatographic control, and it was discontinued, the yarns seemed to be totally converted. The reaction mixture was then diluted with 300 cm 3 of 5% aqueous HCl to make it thinner and then extracted with diethyl ether and the aqueous phase removed. The organic phase was evaporated after drying and the residue was fractionated at atmospheric pressure, collecting a fraction of b.p. 10S-111 ° C. Thus 86 g were obtained, which by chromatographic analysis was found to be 98% pure, which corresponds to a molar yield of 80% relative to Cl

EKSEMPEL IIIEXAMPLE III

Fremstilling af 4-rcyclopropylethyl-thio]-2-nitroanilin.Preparation of 4-cyclopropylethylthio] -2-nitroaniline.

Ved stuetemperatur blev sammenblandet under forsigtig omrøring 51,2 mM 2-nitro-4-thiocyanoanilin opløst I 25 cm dimethylformamid (EMF) og 54 mM natriumborhydrid opløst i 25 cm^ IMF.At room temperature, with gentle stirring, 51.2 mM 2-nitro-4-thiocyanoaniline dissolved in 25 cm 3 of dimethylformamide (EMF) and 54 mM sodium borohydride dissolved in 25 cm 3 of IMF were mixed.

Derpå steg temperaturen af sig selv til 30-35°C.Then the temperature rose to 30-35 ° C by itself.

Blandingen blev holdt under omrøring i 1 (en) time ved stuetemperatur (15-20°C), hvorefter der blev tilsat 66 mM idet tilsætningen blev reguleret således, at man vedligeholdt 8 145121 temperaturen under 25°C. Efter at tilsætningen var blevet tilendebragt, blev blandingen opvarmet til 100°C i 3 timer. Reaktionsmassen blev derpå afkølet og hældt ud i vand under kraftig omrøring. Derpå udførtes extraktion med chloroform; de organiske extrakter blev samlet, tørret på Na2S0^, og opløsningsmidlet blev fjernet under vacuum. Udbyttet af det således dannede råprodukt var 85%, og produktet kan anvendes umiddelbart til den efterfølgende syntese.The mixture was kept under stirring for 1 (one) hour at room temperature (15-20 ° C), after which 66 mM was added, the addition being regulated so as to maintain the temperature below 25 ° C. After the addition was complete, the mixture was heated to 100 ° C for 3 hours. The reaction mass was then cooled and poured into water with vigorous stirring. Then extraction with chloroform; the organic extracts were combined, dried on Na 2 SO 4 and the solvent removed under vacuum. The yield of the crude product thus formed was 85% and the product can be used immediately for the subsequent synthesis.

EKSEMPEL IVEXAMPLE IV

Fremstilling af 4-Γ cyclonronvlethvl-thio1-o-nhenylendiamin 34,4 mM 4-[cyclopropylethyl-thio]-2-nitroanilin blev bragt i suspension i 340 cm af en blanding af methanol og vand i rumfangsforholdet 1:1 og indeholdende 43 g ^2820^.,Preparation of 4-Cyclonronylethyl-thiol-o-nhenylenediamine 34.4 mM 4- [cyclopropylethyl-thio] -2-nitroaniline was suspended in 340 cm of a mixture of methanol and water in a volume ratio of 1: 1 containing 43 g. ^ 2820 ^.,

Reaktionsblandingen blev derpå opvarmet under tilbagesvaling, idet reaktionsforløbet blev overvåget ved tyndtlagschromato-grafi. Reaktionen var tilendebragt i 10-15 minutter. Efter at reaktionen var tilendebragt, blev methanol og en del af vandet fjernet under vacuum, hvorved der dannedes en olieagtig suspension, som blev extraheret med chloroform.The reaction mixture was then heated at reflux, the reaction being monitored by thin layer chromatography. The reaction was complete for 10-15 minutes. After the reaction was complete, methanol and part of the water were removed under vacuum to form an oily suspension which was extracted with chloroform.

De organiske extrakter førte efter tørring over vandfrit NagSO^ og afdampning under vacuum af opløsningsmidlet med praktisk taget kvantitativt udbytte til den rå diamin (en tyktflydende-, meget kraftigt farvet olie), som kan anvendes direkte til det efterfølgende syntesetrin.The organic extracts, after drying over anhydrous NagSO ^ and evaporation under vacuum of the solvent with practically quantitative yield, yielded the crude diamine (a viscous, very vigorously colored oil) which can be used directly for the subsequent synthesis step.

EKSEMPEL VEXAMPLE V

Fremstilling af 5(6)-Γ(cvclonropylethyl)-thiolbenzimidazol- 2-methylcarbamat. 1 20 cm3 af en blanding af C^OH/H^/CH^COOH (40:40:1) blev bragt i dispersion 16 mM 4-[(cyclopropylethyl)-thio]- o-phenylendiamin og 18 mM 1,3-methoxycarbonylisothiourinstof.Preparation of 5 (6) -Γ (cyclonropylethyl) -thiolbenzimidazole-2-methylcarbamate. 1 20 cm 3 of a mixture of C ^OH / H₂ / CH₂COOH (40: 40: 1) was dispersed 16 mM 4 - [(cyclopropylethyl) thio] o-phenylenediamine and 18 mM 1.3 isothiourea.

9 1451219 145121

Blandingen blev derpå holdt under tilbagesvaling i 4 timer.The mixture was then refluxed for 4 hours.

Derpå blev det i reaktionsblandingen således dannede faste stof frafiltreret, og derpå omkrystalliseret ud fra methanol og chloroform (1:1), hvorved man opnåede det ønskede benz-imidazolcarbamat (udbytte = 70%; smp. =187°-189°C).The solid thus formed in the reaction mixture was filtered off and then recrystallized from methanol and chloroform (1: 1) to give the desired benzimidazole carbamate (yield = 70%; mp = 187 ° -189 ° C).

EKSEMPEL VIEXAMPLE VI

Fremstilling af 5(6)-r(cyclopropylethyl)sulfinyl3 benzimidazol- 2-methylcarbamat.Preparation of 5 (6) -r (cyclopropylethyl) sulfinyl 3 benzimidazole-2-methylcarbamate.

I en blanding af CHC17 (400 cm^), methanol (100 cm^) og eddike-In a mixture of CHCl 3 (400 cm 2), methanol (100 cm 3) and vinegar

•Z D• Z D

syre (2 cnr) blev opløst 2,39 mM af den i ovenfor anførte eksempel V dannede ester. Ttemperaturen blev holdt ved 0°C, .og der blev tilsat 2,51 mM m-chlorperbenzoesyre. Efter 1 time var omsætningen tilendebragt som vist ved tyndtlagschromato-grafi (silica-gel - elueringsopløsning: blanding af CHCl^ 3 dele, CH^COOC^ 2 dele, CH^OH 1 del).acid (2 cnr) was dissolved 2.39 mM of the ester formed in the above Example V. The temperature was maintained at 0 ° C and 2.51 mM m-chloroperbenzoic acid was added. After 1 hour, the reaction was completed as shown by thin layer chromatography (silica gel - elution solution: mixture of CHCl 3 parts, CH 2 COOC 2 parts, CH 2 OH 1 part).

Den organiske opløsning blev vasket med 150 ml af en mættet vandig opløsning af natriumhydrogencarbonat; den organiske fase blev tørret på natriumsulfat og inddampet til tørhed under vacuum.The organic solution was washed with 150 ml of a saturated aqueous solution of sodium bicarbonate; the organic phase was dried over sodium sulfate and evaporated to dryness under vacuum.

Den således dannede olieagtige inddampningsrest blev opløst i methanol. Det derudfra udkrystalliserede bundfald førte til sulfoxidet. Efter omkrystallisation fra methanol opnåede man det rene sulfoxid (smeltepunkt 215 °C, udbytte 85%).The oily residue thus formed was dissolved in methanol. The crystallized precipitate from there led to the sulfoxide. After recrystallization from methanol, the pure sulfoxide was obtained (m.p. 215 ° C, yield 85%).

DK442378A 1977-10-06 1978-10-05 METHOD OF ANALOGY FOR PREPARATION OF 5 (6) - (((CYCLOPROPYLETHYL) -SULPHINYL) -BENZIMIDAZOL-2-METHYL CARBAMATE DK145121C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2832277 1977-10-06
IT28322/77A IT1107749B (en) 1977-10-06 1977-10-06 BENZIMIDAZOLCARBAMMATE PARTICULARLY ACTIVE AGAINST GASTROENTERIC AND PULMONARY PARASITES

Publications (3)

Publication Number Publication Date
DK442378A DK442378A (en) 1979-04-07
DK145121B true DK145121B (en) 1982-09-06
DK145121C DK145121C (en) 1983-02-07

Family

ID=11223358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK442378A DK145121C (en) 1977-10-06 1978-10-05 METHOD OF ANALOGY FOR PREPARATION OF 5 (6) - (((CYCLOPROPYLETHYL) -SULPHINYL) -BENZIMIDAZOL-2-METHYL CARBAMATE

Country Status (15)

Country Link
AR (1) AR219768A1 (en)
AT (1) AT359518B (en)
AU (1) AU523667B2 (en)
BR (1) BR7806559A (en)
CA (1) CA1110633A (en)
DE (1) DE2843008A1 (en)
DK (1) DK145121C (en)
FR (1) FR2405248A1 (en)
GB (1) GB1573072A (en)
IE (1) IE47239B1 (en)
IT (1) IT1107749B (en)
NL (1) NL7809973A (en)
NZ (1) NZ188560A (en)
SU (1) SU799660A3 (en)
ZA (1) ZA785663B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599428A (en) * 1979-10-19 1986-07-08 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt Process for the preparation of 5(6)-thio substituted benzimidazoles
US4299837A (en) 1979-12-05 1981-11-10 Montedison S.P.A. Anthelmintic benzimidazole-carbamates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929821A (en) * 1972-12-29 1975-12-30 Syntex Inc 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives
DE2334631A1 (en) * 1973-07-07 1975-03-27 Hoechst Ag 5-PHENYLSULFINYL-2-BENZIMIDAZOLE CARBAMIC ACID ESTERS AND THE METHOD FOR THEIR MANUFACTURE
US3915986A (en) * 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
US4025638A (en) * 1975-03-10 1977-05-24 Smithkline Corporation Methods and compositions using 5-cycloalkylthio- and oxy-2-carbalkoxy-aminobenzimidazole
US4076828A (en) * 1977-02-17 1978-02-28 E. R. Squibb & Sons, Inc. Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles
US4093732A (en) * 1977-02-17 1978-06-06 E. R. Squibb & Sons, Inc. Sulfoxide derivatives of benzimidazoles

Also Published As

Publication number Publication date
SU799660A3 (en) 1981-01-23
GB1573072A (en) 1980-08-13
IE781644L (en) 1979-04-06
AT359518B (en) 1980-11-10
IE47239B1 (en) 1984-01-25
BR7806559A (en) 1979-05-02
NL7809973A (en) 1979-04-10
DK145121C (en) 1983-02-07
CA1110633A (en) 1981-10-13
AU523667B2 (en) 1982-08-12
DE2843008A1 (en) 1979-04-19
AU4034278A (en) 1980-04-17
ZA785663B (en) 1979-09-26
NZ188560A (en) 1981-04-24
ATA717278A (en) 1980-04-15
DE2843008C2 (en) 1988-07-14
FR2405248A1 (en) 1979-05-04
IT1107749B (en) 1985-11-25
FR2405248B1 (en) 1982-10-08
DK442378A (en) 1979-04-07
AR219768A1 (en) 1980-09-15

Similar Documents

Publication Publication Date Title
DE69532245T2 (en) imidazole
EP0001279B1 (en) Imidazole derivatives their synthesis and their pharmaceutical formulations
CH616157A5 (en)
EP0110781B1 (en) Substituted (amino-2-ethyl)-6-benzoxazolinones, their preparation and a pharmaceutical composition containing them
EP0124476B1 (en) Carboxamides, process for their preparation and pharmaceutical preparations containing them
CH627753A5 (en) METHOD FOR PRODUCING NEW SULFONYLBENZIMIDAZOLES.
CH624949A5 (en)
DE2454632A1 (en) NEW 5(6)-SUBSTITUTED BENZIMIDAZOLE-2-CARBAMATS AND THEIR PRODUCTION
DE2029299B2 (en) New aminophenylamidines, processes for their preparation and pharmaceuticals containing them
US2185220A (en) Medicinal agent
DK145121B (en) ANALOGY PROCEDURE FOR PREPARATION OF 5 (6) - ((CYCLOPROPYLETHYL) -SULPHINYL) -BENZIMIDAZOL-2-METHYL CARBAMATE
DE2362754A1 (en) CYCLOPROPYLMETHYLAMINES, THE PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE2449205A1 (en) DIAROMATIC O- (AMINOALKYL) -OXIME, THE PROCESS FOR THEIR MANUFACTURING AND THE MEDICINAL PREPARATIONS CONTAINING THEM
DE2130673A1 (en) Diphenylmethylimidazoles, process for their preparation and their use as fungicides
DE2817370A1 (en) PHENYLTETRAZOLYLOXY PROPANOLAMINE, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL PRODUCTS CONTAINING THESE
DE1115259B (en) Process for the production of iminodibenzylene
DE2332398A1 (en) 2-CARBALCOXY-AMINO-BENZIMIDAZOL-5 (6) PHENYL ETHER, THEIR PRODUCTION AND USE IN AGENTS AGAINST HELMETS
DE2526795A1 (en) SULFONAMIDE
CS197255B2 (en) Method of producing basicly substituted 2-alkoxycarbonyl-amino-benzimidazol-5/6/-ylphenyl esters and ketones
EP0211157A1 (en) Isoxazole derivatives, process for their preparation and phamaceutical compositions containing them
DE2644820A1 (en) (N)-Acyl-2-cyano-aziridine-1-carboxamide and 1-thiocarboxamide derivs. - with carcinostatic and immunostimulant activity
DE2816694C2 (en) 5 (6) -substituted benzimidazole carbamates, their preparation and pharmaceuticals containing them
DE2736268A1 (en) NEW 5-THIAZOLE ALKYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
DD210909A5 (en) METHOD FOR PRODUCING SUBSTITUTED 3,4-DIAMINO-1,2,5-THIADIAZONE COMPOUNDS
EP0114950A1 (en) 1-Cyano-3-(fluoralkyl)guanidines

Legal Events

Date Code Title Description
PBP Patent lapsed